Efficacy And Safety Of Aficamten In Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From The Randomized Evaluation Of Dosing With Ck-3773274 In Hypertrophic Cardiomyopathy Open Label Extension Study

Authors :: Ahmad Masri
Theodore P. Abraham
Lubna Choudhury
Anjali T. Owens
Albree Tower-Rader
Florian Rader
Pablo Garcia-Pavia
Iacopo Olivotto
Caroline Coats
Michael A. Fifer
Scott D. Solomon
Hugh Watkins
Stephen B. Heitner
Daniel Jacoby
Stuart Kupfer
Fady I. Malik
Lisa Meng
Sharon L. Paige
Amy Wohltman
Martin S. Maron
Sara Saberi
Source :: Journal of Cardiac Failure. 29:554
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Tools